Alfredo is Professor of Molecular Biology and former founder and Chief Scientific Officer at Okairos. At Okairos he has contributed to the development of vaccine candidates for HCV, HIV, RSV, Malaria and Ebola.
During his career he held a number of positions in basic research Institutions including the EMBL in Heidelberg, FRG and in pharmaceutical Companies such as Merck.
He holds a degree in Chemistry from the University of Rome and has gained extensive experience in vaccine research and immunology.
He has published over 120 peer-reviewed manuscripts and holds a number of patents and patent applications.